Levelling the SPC playing field

“The EU’s highest court, in a 2013 ruling, held it is possible for a product to be classified as a medical device in one EU member state and a medicine in another.”

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

mRNA litigation: Who’s winning, who’s filing, and what’s next

25 March 2026 As the world moves past the pandemic, a massive legal struggle over the future of mRNA technology is just hitting its stride. LSIPR visualises the litigation defining the next era.

Careers

Dechert boosts litigation bench with partner duo

25 March 2026 Two senior hires from a rival firm bring litigation expertise across life sciences and tech disputes.

Europe

UK court deals blow to Spanish pharma’s SPC bid for contraceptive

24 March 2026 The drugmaker’s attempt to extend protection for a fast-growing oestrogen-free contraceptive ran into a landmark EU ruling, with the court not persuaded to read it narrowly.

More features

EPO reports record patent filings, but pharma and biotech lag

HSF Kramer hires patent litigator as partner in Germany

Emotional Perception: What next for patent holders?

Squire Patton Boggs brings in tech and data expert as Ireland practice lead

Drowning in EU regulations? Five tips for surviving the deluge of new rules

Rooted in rights: Lessons from plant patent infringement and invalidity cases

Why the US is poised for a patent litigation surge in 2026

How AI will be shaped by legal and regulatory developments in 2026

Levelling the SPC playing field

More on this story

Editor's picks

Editor's picks

More features